{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:59:07Z","timestamp":1761253147193},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T00:00:00Z","timestamp":1487980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s40618-017-0636-8","type":"journal-article","created":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T16:00:13Z","timestamp":1488038413000},"page":"663-667","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effect of parathyroid hormone (1\u201384) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis"],"prefix":"10.1007","volume":"40","author":[{"given":"J.","family":"Pepe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. P.","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Vinicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Raimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Biamonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pascone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,25]]},"reference":[{"key":"636_CR1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","volume":"146","author":"SL Greenspan","year":"2007","unstructured":"Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB, Treatment of Osteoporosis with Parathyroid Hormone Study Group (2007) Effect of recombinant human parathyroid hormone (1\u201384) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326\u2013339","journal-title":"Ann Intern Med"},{"issue":"7","key":"636_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40618-016-0437-5","volume":"39","author":"RA Adler","year":"2016","unstructured":"Adler RA (2016) Osteoporosis treatment: complexities and challenges. J Endocrinol Invest 39(7):719\u2013720","journal-title":"J Endocrinol Invest"},{"key":"636_CR3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40618-016-0442-8","volume":"39","author":"EM Lewiecki","year":"2016","unstructured":"Lewiecki EM, Binkley N (2016) What we don\u2019t know about osteoporosis. J Endocrinol Invest 39:491\u2013493","journal-title":"J Endocrinol Invest"},{"key":"636_CR4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","volume":"40","author":"RL Jilka","year":"2007","unstructured":"Jilka RL (2007) Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434\u20131446","journal-title":"Bone"},{"key":"636_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cytogfr.2012.06.003","volume":"24","author":"E Biver","year":"2013","unstructured":"Biver E, Hardouin P, Caverzasio J (2013) The \u201cbone morphogenic proteins\u201d pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets. Cytokine Growth Factor Rev 24:69\u201378","journal-title":"Cytokine Growth Factor Rev"},{"key":"636_CR6","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1210\/endo.140.5.6704","volume":"140","author":"M Suzawa","year":"1999","unstructured":"Suzawa M, Takeuchi Y, Fukumoto S, Kato S, Ueno N, Miyazono K, Matsumoto T, Fujita T (1999) Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 140:2125\u20132133","journal-title":"Endocrinology"},{"key":"636_CR7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.steroids.2013.02.011","volume":"78","author":"Y Matsumoto","year":"2013","unstructured":"Matsumoto Y, Otsuka F, Takano-Narazaki M, Katsuyama T, Nakamura E, Tsukamoto N, Inagaki K, Sada KE, Makino H (2013) Estrogen facilitates osteoblast differentiation by upregulating bone morphogenetic protein-4 signaling. Steroids 78:513\u2013520","journal-title":"Steroids"},{"key":"636_CR8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI15153","volume":"110","author":"H Peng","year":"2002","unstructured":"Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110:751\u2013759","journal-title":"J Clin Invest"},{"key":"636_CR9","first-page":"4","volume":"16","author":"J Street","year":"2009","unstructured":"Street J, Lenehan B (2009) Vascular endothelial growth factor regulates osteoblast survival evidence for an autocrine feedback mechanism. J Orthop Surg Res 16:4\u201319","journal-title":"J Orthop Surg Res"},{"key":"636_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2013.01.028","volume":"54","author":"R Prisby","year":"2013","unstructured":"Prisby R, Menezes T, Campbell J (2013) Vasodilation to PTH (1\u201384) in bone arteries is dependent upon the vascular endothelium and is mediated partially via VEGF signaling. Bone 54:68\u201375","journal-title":"Bone"},{"key":"636_CR11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5114\/aoms.2013.36896","volume":"9","author":"K Senel","year":"2013","unstructured":"Senel K, Baykal T, Seferoglu B, Altas EU, Baygutalp F, Ugur M, Kiziltunc A (2013) Circulating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosis. Arch Med Sci 9:709\u2013712","journal-title":"Arch Med Sci"},{"key":"636_CR12","first-page":"91","volume":"21","author":"H Cebi","year":"2010","unstructured":"Cebi H, Aksahin E, Yuksel HY, Celebi L, Aktekin CN, Ha Pa O (2010) Plasma vascular endothelial growth factor levels are similar in subjects with and without osteoporosis. Eklem Hastalik Cerrahisi 21:91\u201397","journal-title":"Eklem Hastalik Cerrahisi"},{"key":"636_CR13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cyto.2009.03.012","volume":"46","author":"N Costa","year":"2009","unstructured":"Costa N, Paramanathan S, Mac Donald D, Wierzbicki AS, Hampson C (2009) Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis. Cytokine 46:376\u2013381","journal-title":"Cytokine"},{"key":"636_CR14","first-page":"216","volume":"80","author":"VE Dincel","year":"2014","unstructured":"Dincel VE, Sepici-Dincel A (2014) The importance and the differences of bone morphogenetic proteins for osteoporotic hip fractures. Acta Orthop Belg 80:216\u2013221","journal-title":"Acta Orthop Belg"},{"key":"636_CR15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"9","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. JBMR 9:1137\u20131148.","journal-title":"JBMR"},{"key":"636_CR16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00223-011-9513-1","volume":"89","author":"S Russo","year":"2011","unstructured":"Russo S, Carlucci L, Cipriani C, Ragno A, Piemonte S, Fiacco Rd, Pepe J, Fassino V, Arima S, Romagnoli E, Minisola S (2011) Metabolic changes following 500\u00a0\u03bcg monthly administration of calcidiol: a study in normal females. Calcif Tissue Int 89:252\u2013257","journal-title":"Calcif Tissue Int"},{"key":"636_CR17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/clinchem\/47.7.1314","volume":"47","author":"F Paglia","year":"2001","unstructured":"Paglia F, Dionisi S, De Geronimo S, Rosso R, Romagnoli E, Raejntroph N, Ragno A, Celi M, Pepe J, D\u2019Erasmo E, Minisola S (2001) Biomarkers of bone turnover after a short period of steroid therapy in elderly men. Clin Chem 47:1314\u20131316","journal-title":"Clin Chem"},{"key":"636_CR18","doi-asserted-by":"crossref","first-page":"E1670","DOI":"10.1152\/ajpendo.00287.2007","volume":"293","author":"S Brunner","year":"2007","unstructured":"Brunner S, Theiss HD, Murr A, Negele T, Franz WM (2007) Primary hyperparathyroidism is associated with increased circulating bonemarrow-derived progenitor cells. Am J Physiol Endocrinol Metab 293:E1670\u2013E1675","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"636_CR19","doi-asserted-by":"crossref","first-page":"E2025","DOI":"10.1210\/jc.2014-1500","volume":"99","author":"NE Cusano","year":"2014","unstructured":"Cusano NE, Rubin MR, Zhang C, Anderson L, Levy E, Costa AG, Irani D, Bilezikian JP (2014) Parathyroid hormone 1\u201384 alters circulating vascular endothelial growth factor levels in hypoparathyroidism. J Clin Endocrinol Metab 99:E2025\u2013E2028","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1510187","volume":"151","author":"G Christodoulakos","year":"2004","unstructured":"Christodoulakos G, Lambrinoudaki I, Panoulis C, Papadias C, Sarandakou A, Liakakos T, Alexandrou A, Creatsas G (2004) Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women. Eur J Endocrinol 151:187\u2013192","journal-title":"Eur J Endocrinol"},{"key":"636_CR21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.090806","volume":"25","author":"N Kamiya","year":"2010","unstructured":"Kamiya N, Kobayashi T, Mochida Y, Yu PB, Yamauchi M, Kronenberg HM, Mishina YJ (2010) Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. JBMR 25:200\u2013210.","journal-title":"JBMR"},{"key":"636_CR22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2010-2552","volume":"96","author":"D Gatti","year":"2011","unstructured":"Gatti D, Viapiana O, Idolazzi L, Fracassi E, Rossini M, Adami S (2011) The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1. J Clin Endocrinol Metab 96:1555\u20131559","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR23","first-page":"866","volume":"35","author":"S Piemonte","year":"2012","unstructured":"Piemonte S, Romagnoli E, Bratengeier C, Woloszczuk W, Tancredi A, Pepe J, Cipriani C, Minisola S (2012) Serum sclerostin levels decline in postmenopausal women with osteoporosis following treatment with intermittent PTH. J Endocrinol Invest 35:866\u2013868","journal-title":"J Endocrinol Invest"},{"key":"636_CR24","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, Srinivasan B, M\u00f6dder UI, Peterson JM, McCready LK, Riggs BL, Dwyer D, Stolina M, Kostenuik P, Khosla S (2010) Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 95:5056\u20135062","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00198-010-1222-5","volume":"22","author":"A Lasco","year":"2011","unstructured":"Lasco A, Catalano A, Morabito N, Gaudio A, Basile G, Trifiletti A, Atteritano M (2011) Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis. Osteoporos Int 22:299\u2013303","journal-title":"Osteoporos Int"},{"key":"636_CR26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/08977190802277880","volume":"26","author":"CA Luppen","year":"2008","unstructured":"Luppen CA, Chandler RL, Noh T, Mortlock DP, Frenkel B (2008) BMP-2 versus BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization. Growth Factors 26:226\u2013237","journal-title":"Growth Factors"},{"key":"636_CR27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bone.2003.08.002","volume":"33","author":"T Pufe","year":"2003","unstructured":"Pufe T, Scholz-Ahrens KE, Franke AT, Petersen W, Mentlein R, Varoga D, Tillmann B, Schrezenmeir J, Gl\u00fcer CC (2003) The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model. Bone 33:869\u2013876","journal-title":"Bone"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0636-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0636-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0636-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T18:08:32Z","timestamp":1719079712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0636-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,25]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0636-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,25]]}}}